Use of polyvalent coagglutination reagents for serotyping of Streptococcus suis

M. Gottschalk, Robert Higgins, M. Boudreau

Research output: Contribution to journalComment/debate

52 Citations (Scopus)

Abstract

Polyvalent coagglutination reagents (PRs) have been evaluated for the serotyping of Streptococcus suis. Monovalent antisera produced against 28 S. suis reference strains have been grouped to obtain five different pools. A total of 249 field isolates previously identified and belonging to different serotypes were tested with PRs prepared by two different procedures: (i) monovalent coagglutination reagents were individually prepared and mixed in equal proportions, and (ii) antisera were mixed in equal proportions before the addition of the Staphylococcus aureus suspension. Only antisera tested by a tube agglutination test with 2-mercaptoethanol and presenting titers of 1:32 or higher were used. Results obtained with PRs prepared by both procedures were similar, and there was a very good correlation between the capsular type of the isolate and the reaction obtained with PRs. Thus, from a practical viewpoint, it is suggested that PRs be prepared by the first procedure. To validate this methodology, a total of 577 S. suis field isolates, consisting of 486 typeable and 91 untypeable isolates, were tested in parallel with both the PRs and the monovalent coagglutination reagents over a 1-year period. Ninety-nine percent of the typeable and all of the untypeable isolates were correctly identified. Serotyping with PRs is suggested to be a very useful and reliable screening procedure, particularly when a large number of S. suis isolates have to be serotyped. In addition, the choice of antisera to be included in a given pool is facultative and should be oriented to the needs of a region or a country.

Original languageEnglish (US)
Pages (from-to)2192-2194
Number of pages3
JournalJournal of Clinical Microbiology
Volume31
Issue number8
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Streptococcus suis
Serotyping
Immune Sera
Agglutination Tests
Mercaptoethanol
Staphylococcus aureus
Suspensions

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

Use of polyvalent coagglutination reagents for serotyping of Streptococcus suis. / Gottschalk, M.; Higgins, Robert; Boudreau, M.

In: Journal of Clinical Microbiology, Vol. 31, No. 8, 01.01.1993, p. 2192-2194.

Research output: Contribution to journalComment/debate

@article{c880f3c938e64ed0a964b37d30ad43eb,
title = "Use of polyvalent coagglutination reagents for serotyping of Streptococcus suis",
abstract = "Polyvalent coagglutination reagents (PRs) have been evaluated for the serotyping of Streptococcus suis. Monovalent antisera produced against 28 S. suis reference strains have been grouped to obtain five different pools. A total of 249 field isolates previously identified and belonging to different serotypes were tested with PRs prepared by two different procedures: (i) monovalent coagglutination reagents were individually prepared and mixed in equal proportions, and (ii) antisera were mixed in equal proportions before the addition of the Staphylococcus aureus suspension. Only antisera tested by a tube agglutination test with 2-mercaptoethanol and presenting titers of 1:32 or higher were used. Results obtained with PRs prepared by both procedures were similar, and there was a very good correlation between the capsular type of the isolate and the reaction obtained with PRs. Thus, from a practical viewpoint, it is suggested that PRs be prepared by the first procedure. To validate this methodology, a total of 577 S. suis field isolates, consisting of 486 typeable and 91 untypeable isolates, were tested in parallel with both the PRs and the monovalent coagglutination reagents over a 1-year period. Ninety-nine percent of the typeable and all of the untypeable isolates were correctly identified. Serotyping with PRs is suggested to be a very useful and reliable screening procedure, particularly when a large number of S. suis isolates have to be serotyped. In addition, the choice of antisera to be included in a given pool is facultative and should be oriented to the needs of a region or a country.",
author = "M. Gottschalk and Robert Higgins and M. Boudreau",
year = "1993",
month = "1",
day = "1",
language = "English (US)",
volume = "31",
pages = "2192--2194",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - Use of polyvalent coagglutination reagents for serotyping of Streptococcus suis

AU - Gottschalk, M.

AU - Higgins, Robert

AU - Boudreau, M.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Polyvalent coagglutination reagents (PRs) have been evaluated for the serotyping of Streptococcus suis. Monovalent antisera produced against 28 S. suis reference strains have been grouped to obtain five different pools. A total of 249 field isolates previously identified and belonging to different serotypes were tested with PRs prepared by two different procedures: (i) monovalent coagglutination reagents were individually prepared and mixed in equal proportions, and (ii) antisera were mixed in equal proportions before the addition of the Staphylococcus aureus suspension. Only antisera tested by a tube agglutination test with 2-mercaptoethanol and presenting titers of 1:32 or higher were used. Results obtained with PRs prepared by both procedures were similar, and there was a very good correlation between the capsular type of the isolate and the reaction obtained with PRs. Thus, from a practical viewpoint, it is suggested that PRs be prepared by the first procedure. To validate this methodology, a total of 577 S. suis field isolates, consisting of 486 typeable and 91 untypeable isolates, were tested in parallel with both the PRs and the monovalent coagglutination reagents over a 1-year period. Ninety-nine percent of the typeable and all of the untypeable isolates were correctly identified. Serotyping with PRs is suggested to be a very useful and reliable screening procedure, particularly when a large number of S. suis isolates have to be serotyped. In addition, the choice of antisera to be included in a given pool is facultative and should be oriented to the needs of a region or a country.

AB - Polyvalent coagglutination reagents (PRs) have been evaluated for the serotyping of Streptococcus suis. Monovalent antisera produced against 28 S. suis reference strains have been grouped to obtain five different pools. A total of 249 field isolates previously identified and belonging to different serotypes were tested with PRs prepared by two different procedures: (i) monovalent coagglutination reagents were individually prepared and mixed in equal proportions, and (ii) antisera were mixed in equal proportions before the addition of the Staphylococcus aureus suspension. Only antisera tested by a tube agglutination test with 2-mercaptoethanol and presenting titers of 1:32 or higher were used. Results obtained with PRs prepared by both procedures were similar, and there was a very good correlation between the capsular type of the isolate and the reaction obtained with PRs. Thus, from a practical viewpoint, it is suggested that PRs be prepared by the first procedure. To validate this methodology, a total of 577 S. suis field isolates, consisting of 486 typeable and 91 untypeable isolates, were tested in parallel with both the PRs and the monovalent coagglutination reagents over a 1-year period. Ninety-nine percent of the typeable and all of the untypeable isolates were correctly identified. Serotyping with PRs is suggested to be a very useful and reliable screening procedure, particularly when a large number of S. suis isolates have to be serotyped. In addition, the choice of antisera to be included in a given pool is facultative and should be oriented to the needs of a region or a country.

UR - http://www.scopus.com/inward/record.url?scp=0027250328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027250328&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 8370749

AN - SCOPUS:0027250328

VL - 31

SP - 2192

EP - 2194

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 8

ER -